Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S278.
doi: 10.21037/atm.2019.11.141.

Epigallocatechin gallate in multiple system atrophy (PROMESA)

Kurt A Jellinger  1
Affiliations
Editorial

Epigallocatechin gallate in multiple system atrophy (PROMESA)

Kurt A Jellinger. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Comment on

References

    1. Krismer F, Wenning GK. Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol 2017;13:232-43. 10.1038/nrneurol.2017.26 - DOI - PubMed
    1. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-6. 10.1212/01.wnl.0000324625.00404.15 - DOI - PMC - PubMed
    1. Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007;33:615-20. 10.1111/j.1365-2990.2007.00907.x - DOI - PubMed
    1. Cykowski MD, Coon EA, Powell SZ, et al. Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 2015;138:2293-309. 10.1093/brain/awv114 - DOI - PMC - PubMed
    1. Goedert M, Masuda-Suzukake M, Falcon B. Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 2017;140:266-78. 10.1093/brain/aww230 - DOI - PubMed